American Society of Clinical Oncology technology assessment working group update: use of aromatase inhibitors in the adjuvant setting.
Winer
Eric P
EP
American Society of Clinical Oncology, Alexandria, VA 22314, USA.
Hudis
Clifford
C
Burstein
Harold J
HJ
Bryant
John
J
Chlebowski
Rowan T
RT
Ingle
James N
JN
Edge
Stephen B
SB
Mamounas
Eleftherios P
EP
Gelber
Richard
R
Gralow
Julie
J
Goldstein
Lori J
LJ
Pritchard
Kathleen I
KI
Braun
Susan
S
Cobleigh
Melody A
MA
Langer
Amy S
AS
Perotti
Judy
J
Powles
Trevor J
TJ
Whelan
Timothy J
TJ
Browman
George P
GP
D047072:Aromatase Inhibitors; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016134:Organizational Policy; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D012955:Societies, Medical; D013534:Survival
D047072:Aromatase Inhibitors; D004791:Enzyme Inhibitors